Tirzepatide activates both GIP and GLP-1 pathways to help reduce appetite and food intake. It is a strong fit for patients who want a highly effective, provider-guided weight-loss option.
EffectivenessIn a 72-week study, tirzepatide produced about 15% to 20.9% average body-weight loss depending on dose, alongside diet and activity.
How it is takenTypically taken once weekly under provider direction, beginning with a lower starter dose before gradual increases if appropriate.
Usual program lengthMost patients plan for at least 3–6 months so the medication can be titrated thoughtfully and progress can be monitored.
Average weekly lossClinical averages are roughly 0.5–0.7 lb per week over long trials, though real-world results vary by dose, habits, and physiology.
Bundle options3- and 6-month bundles are highlighted on the checkout page for patients ready to commit to a longer, structured plan.
Personalized careYour program is shaped around your history, weight-loss target, comfort level, and follow-up with a licensed provider.